Actuate Corporation (NASDAQ: ACTU)(NASDAQ: BIRT), the people
behind BIRT® and the leading open source Business Intelligence
vendor, today announced financial results for the third quarter of
2010.
Third Quarter Financial and Operational Highlights:
- Record non-GAAP revenue of $40.5
million, up 38% year-over-year;
- Q3 license revenues of $17.8 million,
up 106% year-over-year;
- Record non-GAAP operating margins of
36%;
- Record non-GAAP diluted EPS of $0.23,
up 156% year-over-year;
- Year-to-date operating cash flow of
$19.0 million, up 63% year-over-year;
- Over $5.1 million in BIRT-related
business for Q3; up 8% over the prior year, year-to-date
BIRT-related license business up over 50%;
- Booked more than 140 BIRT-related
transactions in Q3, bringing the total since beginning of 2008 to
over 1,200;
- Q3 revenue included three transactions
with a license component in excess of $1.0 million.
“We had a solid third quarter, with many positives to highlight
across the business, including a positive resolution with IBM and
continued BIRT momentum,” said Pete Cittadini, President and CEO of
Actuate. “BIRT is recognized as a Leader in open source BI. There
are now over one million BIRT developers worldwide and we passed
the 10 million BIRT downloads mark.”
Tweet this: #Actuate ACTU Q3 License Rev +106% YOY;
Non-GAAP Diluted EPS $0.23; #BIRT Downloads 10MM+
Revenues as reported in accordance with U.S. generally accepted
accounting principles (GAAP) for the third quarter of 2010 were
$39.8 million, compared with $29.4 million in the third quarter of
2009. License revenues for the third quarter of 2010 were $17.8
million, up 106% when compared with $8.6 million in the year-ago
quarter. Included in the third quarter revenues is $11.0 million
related to the favorable resolution of a software licensing dispute
with IBM. Maintenance revenues for the quarter were $20.1 million,
compared with $19.3 million reported in the same quarter last year.
Professional services revenues for the third quarter of 2010
totaled $1.9 million, compared with $1.4 million in the third
quarter of 2009. On a non-GAAP basis, total revenues for Q3 were
$40.5 million. The difference between GAAP and non-GAAP revenue is
approximately $0.7 million of maintenance revenue that was not able
to be recognized due to the impact of purchase accounting on the
acquired Xenos revenue contracts.
GAAP operating income was $11.6 million for the third quarter of
2010, compared with $4.3 million in the third quarter of 2009. Net
income for the third quarter of 2010, as reported in accordance
with U.S. generally accepted accounting principles (GAAP), was $7.0
million, or $0.14 per diluted share, compared with $3.1 million or
$0.06 per diluted share in the third quarter of 2009.
Cash flow from operations was $6.9 million for the third quarter
of 2010. Year-to-date cash flow from operations is $19.0 million,
up 63% year-over-year. Cash, cash equivalents and short-term
investments totaled $73.5 million on September 30, 2010, up from
$63.6 million at June 30, 2010.
Non-GAAP net income for the third quarter of 2010 was $11.3
million, or $0.23 per diluted share, compared with non-GAAP net
income of $4.4 million, or $0.09 per diluted share in the third
quarter of 2009. Non-GAAP operating margin for the third quarter of
2010 was 36%, compared with 21% for the prior year.
Third Quarter 2010 Business Highlights
- Quarterly BIRT-related business of over
$5.1 million; up 8% year-over-year;
- BIRT life-to-date downloads cross 10
million threshold;
- Actuate now estimates over 1 million
developers as part of its open source BIRT community;
- Completed more than 140 BIRT-related
transactions;
- Launched ActuateOne, a game changing
product suite for rapidly developing and deploying custom Business
Intelligence (BI) applications and information applications;
- ActuateOne includes BIRT based
technology for analytics, dashboarding, cloud deployment and
integration with Xenos technology to increase the array of
applications that can be built using BIRT;
- Announced the general availability of
BIRT onDemand, a Platform as a Service (PaaS) offering based on
Actuate’s industry standard and massively scalable BIRT
iServer;
- Actuate with its value added offerings
for BIRT have been recognized as a Leader in “The Forrester Wave™:
Open Source Business Intelligence (BI), Q3 2010” report;
- Announced the general availability of
Xenos Enterprise Server 2.0 which enhances online presentment and
optimizes Enterprise Content Management investments;
- Raymond L. Ocampo Jr., an esteemed
Silicon Valley leader with extensive enterprise software company
expertise joined Actuate’s Board of Directors.
During the third quarter, Actuate received significant new
and repeat business from, among others: Callidus Software,
Inc., CGI Group, Inc., CIBC Finance, Inc., Cisco Systems, Inc.,
Coventry Health Care, Defense Integrated Military Human Resources
System, IBM Inc., Educational Testing Service, Harland Financial
Solutions, Inc., Infor Global Solutions, MetLife, Inc., Sungard
Investment Systems, LLC, UBS Wealth Management Australia Ltd. and
UBS AG.
Conference Call Information
Actuate will be holding a conference call at 5:00 p.m. Eastern
Time, today, November 2nd, 2010 to further discuss these results.
The dial-in number for the call is 1-877-407-8035 (201-689-8035 for
international participants) and the conference ID is #358320. The
conference call will be broadcast live on the Investor Relations
section of Actuate’s web site at http://www.actuate.com/investor
and will be available as an archived replay for 30 days
thereafter.
Actuate – The people behind BIRT
Actuate founded and co-leads the Eclipse BIRT open source
project. ActuateOne is a unified suite of products for rapidly
developing and deploying BIRT-based custom Business Intelligence
applications and information applications. Applications built with
ActuateOne provide one user experience regardless of task or
skill level; are supported by one server for any deployment
including cloud and are built with one BIRT design that can
access and integrate any data source - including high volume print
streams. ActuateOne adds rich data visualizations, including
interactivity, dashboards, analytics, and deployment options to web
and mobile BIRT applications, helping organizations drive revenue
through higher customer satisfaction and improved operational
performance.
Actuate has over 4,600 customers globally in a diverse range of
business areas including financial services and the public sector.
Founded in 1993, Actuate is headquartered in San Mateo, California,
with offices worldwide. Actuate is listed on NASDAQ under the
symbol BIRT. For more information, visit the company’s web site at
www.actuate.com or visit the BIRT community at
www.birt-exchange.com.
Discussion of Non-GAAP Financial Measures
This press release contains financial measures that are not
calculated in accordance with U.S. generally accepted accounting
principles (GAAP). Actuate management evaluates and makes operating
decisions using various performance measures. In addition to our
GAAP results, we also consider adjusted net income, which we refer
to as non-GAAP net income. We further consider various components
of non-GAAP net income such as non-GAAP gross margin and non-GAAP
operating expense. Non-GAAP net income is generally based on the
revenues of our product, maintenance and services business
operations and the costs of those operations, such as cost of
revenue, research and development, sales and marketing and general
and administrative expenses, that management considers in
evaluating our ongoing core operating performance. Non-GAAP net
income consists of net income excluding amortization of intangible
assets, restructuring charges, equity plan-related compensation
expenses, acquisition related expenses, and other charges and gains
which management does not consider reflective of our core operating
business. Non-GAAP net income also includes an adjustment to add
back revenue that could not be recognized due to the impact of
purchase accounting on the acquired Xenos revenue contracts.
Intangible assets consist primarily of purchased technology, trade
names, customer relationships, employment agreements and other
intangible assets issued in connection with acquisitions.
Restructuring charges consist of severance and benefits, excess
facilities and asset-related charges and include strategic
reallocations or reductions of personnel resources. Equity
plan-related compensation expenses represent the fair value of all
share-based payments to employees, including grants of employee
stock options. For purposes of comparability across other periods
and against other companies in our industry, non-GAAP net income is
adjusted by the amount of additional taxes or tax benefit that the
Company would accrue using a normalized effective tax rate applied
to the non-GAAP results. Our non-GAAP earnings per share
calculation also includes an adjustment to total outstanding shares
to reflect what the share amount would have been if it were
calculated using non-GAAP results.
Non-GAAP net income is a supplemental measure of our performance
that is not required by, nor presented in accordance with, GAAP.
Moreover, it should not be considered as an alternative to net
income, operating income, or any other performance measure derived
in accordance with GAAP, or as an alternative to cash flow from
operating activities or as a measure of our liquidity. We present
non-GAAP net income because we consider it an important
supplemental measure of our performance.
Management excludes from non-GAAP net income certain recurring
items to facilitate its review of the comparability of the
Company's core operating performance on a period-to-period basis
because such items are not related to the Company's ongoing core
operating performance as viewed by management. Management uses this
view of its operating performance for purposes of comparison with
its business plan and individual operating budgets and allocations
of resources. Additionally, when evaluating potential acquisitions,
management excludes the items described above from its
consideration of target performance and valuation.
The Company believes that, in general, these items possess one
or more of the following characteristics: their magnitude and
timing is largely outside of the Company's control; they are
unrelated to the ongoing operation of the business in the ordinary
course; they are unusual and the Company does not expect them to
occur in the ordinary course of business; or they are
non-operational, or non-cash expenses involving stock option
grants.
The Company believes that the presentation of these non-GAAP
financial measures is warranted for several reasons:
1) Such non-GAAP financial measures provide an additional
analytical tool for understanding the Company's financial
performance by excluding the impact of items that may obscure
trends in the core operating performance of the business;
2) Since the Company has historically reported non-GAAP results
to the investment community, the Company believes the inclusion of
non-GAAP numbers provides consistency and enhances investors'
ability to compare the Company's performance across financial
reporting periods;
3) These non-GAAP financial measures are employed by the
Company's management in its own evaluation of performance and are
utilized in financial and operational decision making processes,
such as budget planning and forecasting;
4) These non-GAAP financial measures facilitate comparisons to
the operating results of other companies in our industry, which use
similar financial measures to supplement their GAAP results, thus
enhancing the perspective of investors who wish to utilize such
comparisons in their analysis of the Company's performance.
Set forth below are additional reasons why specific items are
adjusted in the Company's non-GAAP financial measures:
a) Amortization charges for purchased technology and other
intangible assets are excluded because they are inconsistent in
amount and frequency and are significantly impacted by the timing
and magnitude of the Company's acquisition transactions. We analyze
and measure our operating results without these charges when
evaluating our core performance. Generally, the impact of these
charges to the Company's net income tends to diminish over time
following an acquisition.
b) While stock-based compensation constitutes an ongoing and
recurring expense of the Company, it is not an expense that
typically requires or will require cash settlement by the Company.
We therefore exclude these charges for purposes of evaluating our
core performance as well as with respect to evaluating any
potential acquisition.
c) Restructuring charges are primarily related to severance
costs and/or the disposition of excess facilities driven by
modifications of business strategy. These costs are excluded
because they are inherently variable in size, and are not
specifically included in the Company's annual operating plan and
related budget due to the rapidly changing facts and circumstances
typically associated with such modifications of business
strategy.
d) Acquisition related costs are costs incurred in concluding
our acquisition of Xenos Group, Inc. The acquisition was closed in
February 2010. These costs are excluded because they are
inconsistent in amount and frequency and are directly impacted by
the timing and magnitude of the Company's acquisition transactions.
We analyze and measure our operating results without these charges
when evaluating our core performance. These acquisition-related
costs are unrelated to the Company's core operations in the
ordinary course and are not included in our annual operating plan
and related budget.
e) The deferred revenue adjustment relates to our acquisition of
Xenos Group, Inc, which was concluded in February 2010. In
accordance with the fair value provisions of Accounting Standards
Codification (“ASC”) 805, Business Combination, acquired deferred
revenue of approximately $1.5 million was recorded on the opening
balance sheet, which was approximately $3.1 million lower than the
historical carrying value. This purchase accounting requirement
adversely impacts the Company's reported GAAP revenue primarily for
the first twelve months post-acquisition. In order to provide
investors with financial information that facilitates comparison of
both historical and future results, the Company has provided
non-GAAP financial measures which exclude the impact of the
purchase accounting adjustment. The Company believes that this
non-GAAP financial adjustment is useful to investors because it
allows investors to (a) evaluate the effectiveness of the
methodology and information used by management in its financial and
operational decision-making and (b) compare past and future reports
of financial results of the Company as the revenue reduction
related to acquired deferred revenue will not recur when related
terms are renewed in future periods.
f) Income tax expense is adjusted by the amount of additional
expense or benefit that we would accrue if we used non-GAAP results
instead of GAAP results in the calculation of our tax liability,
taking into consideration the Company's long-term tax structure.
The Company is using a normalized effective tax rate of 20%. This
item is excluded because the rate remains subject to change based
on several factors, including variations over time in the
geographic business mix and statutory tax rates.
In the future, the Company expects to continue reporting
non-GAAP financial measures excluding items described above and the
Company expects to continue to incur expenses similar to the
non-GAAP adjustments described above. Accordingly, exclusion of
these and other similar items in our non-GAAP presentation should
not be construed as an inference that these costs are unusual,
infrequent or non-recurring.
As stated above, the Company presents non-GAAP financial
measures because it considers them to be important supplemental
measures of performance. However, non-GAAP financial measures have
limitations as an analytical tool and should not be considered in
isolation or as a substitute for the Company's GAAP results. In the
future, the Company expects to incur expenses similar to the
non-GAAP adjustments described above and expects to continue
reporting non-GAAP financial measures excluding such items. Some of
the limitations in relying on non-GAAP financial measures are:
- Amortization of intangibles, though not
directly affecting our current cash position, represent the loss in
value as the technology in our industry evolves, is advanced or is
replaced over time. The expense associated with this loss in value
is not included in the non-GAAP net income presentation and
therefore does not reflect the full economic effect of the ongoing
cost of maintaining our current technological position in our
competitive industry, which is addressed through our research and
development program.
- The Company may engage in acquisition
transactions in the future. Merger and acquisition related charges
may therefore continue to be incurred and should not be viewed as
non-recurring.
- The Company's stock option and stock
purchase plans are important components of our incentive
compensation arrangements and will be reflected as expenses in our
GAAP results for the foreseeable future.
- The Company's income tax expense will
be ultimately based on its GAAP taxable income and actual tax rates
in effect, which may differ significantly from the 20% rate assumed
in our non-GAAP presentation.
- Other companies, including other
companies in our industry, may calculate non-GAAP financial
measures differently than we do, limiting their usefulness as a
comparative measure.
Pursuant to the requirements of SEC Regulation G, a detailed
reconciliation between the Company's GAAP and non-GAAP financial
results is provided in this press release and is available in the
investor relations section of the Company's web site for a limited
time at http://www.actuate.com/investor. Investors are advised to
carefully review and consider this information strictly as a
supplement to the GAAP results that are contained in this press
release and in the Company's SEC filings.
Cautionary Note Regarding Forward Looking Statements: The
statements contained in this press release that are not purely
historical are forward looking statements within the meaning of
Section 21E of the Securities Exchange Act of 1934. These
include statements regarding Actuate’s expectations, beliefs,
hopes, intentions or strategies regarding the future. All
such forward-looking statements are based upon information
available to Actuate as of the date hereof, and Actuate disclaims
any obligation to update or revise any such forward-looking
statements based on changes in expectations or the circumstances or
conditions on which such expectations may be based. Actual
results could differ materially from Actuate’s current
expectations. Factors that could cause or contribute to such
differences include, but are not limited to, the general spending
environment for information technology products and services in
general and Rich Internet Application, performance management, and
print stream software in particular, quarterly fluctuations in our
revenues and other operating results, our ability to expand our
international operations, our ability to successfully compete
against current and future competitors, the impact of future
acquisitions (including the Xenos Group Inc. acquisition) on the
Company’s financial and/or operating condition, the ability to
increase revenues through our indirect distribution channels,
general economic and geopolitical uncertainties and other risk
factors that are discussed in Actuate’s Securities and Exchange
Commission filings, specifically Actuate 2009 Annual Report on Form
10-K filed on March 10, 2010.
Copyright © 2010 Actuate Corporation. All rights reserved.
Actuate and the Actuate logo are registered trademarks of Actuate
Corporation and/or its affiliates in the U.S. and certain other
countries. All other brands, names or trademarks mentioned may be
trademarks of their respective owners.
ACTUATE CORPORATION
CONDENSED CONSOLIDATED BALANCE SHEETS (in thousands)
(unaudited) September 30,
December 31,
2010 2009 ASSETS Current assets: Cash,
cash equivalents and short-term investments $ 73,540 $ 75,531
Accounts receivable, net 20,590 33,176 Other current assets
5,780 5,667 Total current assets 99,910 114,374 Property and
equipment, net 3,377 3,786 Goodwill and other intangibles, net
62,739 37,014 Other assets 15,483 14,590 $ 181,509 $
169,764
LIABILITIES AND STOCKHOLDERS' EQUITY Current
liabilities: Accounts payable $ 1,560 $ 1,372 Restructuring
liabilities 2,035 2,796 Accrued compensation 5,888 4,918 Other
accrued liabilities 4,204 5,330 Income taxes payable 1,046 845
Deferred revenue 39,084 44,999 Total current
liabilities 53,817 60,260 Long term
liabilities: Notes payable 40,000 30,000 Other deferred liabilities
489 769 Deferred revenue 1,175 1,288 Tax liabilities 356 806
Restructuring liabilities - 622 Total long term
liabilities 42,020 33,485 Stockholders' equity
& non-controlling interest 85,672 76,019 $
181,509 $ 169,764
ACTUATE CORPORATION CONSOLIDATED
STATEMENTS OF OPERATIONS (in thousands, except per share
data) (unaudited)
Three Months Ended Nine Months Ended September
30, September 30, 2010 2009
2010 2009 Revenues: License fees $
17,765 $ 8,620 $ 37,387 $ 25,907 Maintenance 20,077 19,340 56,037
56,889 Professional services 1,925 1,391
5,707 5,352 Total revenues
39,767 29,351 99,131
88,148 Costs and expenses: Cost of license
fees 651 267 1,589 703 Cost of services 4,970 4,185 14,596 13,718
Sales and marketing 10,767 10,231 30,468 31,433 Research and
development 6,304 4,998 18,574 15,256 General and administrative
4,916 5,085 19,288 14,717 Amortization of other intangibles 529 170
1,351 510 Restructuring charges 7 129
671 240 Total costs and expenses
28,144 25,065 86,537
76,577 Income from operations 11,623 4,286 12,594 11,571
Interest income and other income/(expense), net 25 (405 ) (860 )
179 Interest expense (424 ) (347 ) (1,296 )
(1,057 ) Income before income taxes 11,224 3,534 10,438
10,693 Provision for income taxes 4,269 395
2,518 1,951 Net income
6,955 3,139 7,920 8,742
Basic net income per share $ 0.16 $ 0.07 $
0.18 $ 0.19 Shares used in basic per share
calculation 44,669 45,580 45,002
45,026 Diluted net income per share $ 0.14
$ 0.06 $ 0.16 $ 0.18 Shares used in
diluted per share calculation 48,425 50,484
49,046 49,235
ACTUATE
CORPORATION RECONCILIATION OF GAAP TO NON-GAAP FINANCIAL
MEASURES (in thousands, except per share data)
(unaudited)
Three Months Ended Nine Months Ended Revenue
reconciliation: September 30, (a)
September
30, (a)
2010 2009
Notes 2010 2009
Notes GAAP revenue $ 39,767 $ 29,351 $ 99,131 $ 88,148
Non-GAAP adjustments: Deferred revenue adjustment - Xenos
776 - (g) 2,836 -
(g) Total non-GAAP revenues $ 40,543 $ 29,351 $
101,967 $ 88,148
Three Months
Ended Nine Months Ended September 30, (a)
September 30, (a)
Operating expense
reconciliation: 2010 2009
Notes 2010 2009
Notes GAAP operating expenses $ 28,144 $
25,065 $ 86,537 $ 76,577 Non-GAAP adjustments: Amortization of
purchased technology (328 ) (55 ) (b) (894 ) (165 ) (b)
Amortization of other intangibles (529 ) (170 ) (c) (1,351 ) (510 )
(c) Stock-based compensation expense (1,243 ) (1,604 ) (d) (4,239 )
(5,367 ) (d) Restructuring charges (7 ) (129 ) (e) (671 ) (240 )
(e) Acquisition related costs - - (f)
(635 ) - (f) Total non-GAAP operating expenses
$ 26,037 $ 23,107 $ 78,747 $ 70,295
Three Months Ended Nine Months Ended
Operating income reconciliation: September 30,
(a)
September 30, (a)
2010
2009 Notes
2010 2009 Notes
Total non-GAAP revenues $ 40,543 $ 29,351 $ 101,967 $ 88,148
Total non-GAAP operating expenses
(26,037 ) (23,107 ) (78,747 ) (70,295 )
Total non-GAAP operating income $ 14,506 $ 6,244 $
23,220 $ 17,853
Three Months
Ended Nine Months Ended Net income
reconciliation: September 30, (a)
September
30, (a)
2010 2009
Notes 2010 2009
Notes GAAP income before income taxes $ 11,224 $
3,534 $ 10,438 $ 10,693 Non-GAAP adjustments: Amortization of
purchased technology 328 55 (b) 894 165 (b) Amortization of other
intangibles 529 170 (c) 1,351 510 (c) Stock-based compensation
expense 1,243 1,604 (d) 4,239 5,367 (d) Restructuring charges 7 129
(e) 671 240 (e) Acquisition related costs - - (f) 635 - (f)
Deferred revenue adjustment - Xenos 776 -
(g) 2,836 - (g) Non-GAAP income
before income taxes 14,107 5,492 21,064 16,975 Non-GAAP tax
provision 2,821 1,098 (h) 4,212
3,395 (h) Non-GAAP net income 11,286
4,394 16,852 13,580
Basic non-GAAP net income per share $ 0.25 $ 0.10
$ 0.37 $ 0.30 Shares used in basic per share
calculation 44,669 45,580 45,002
45,026 Diluted non-GAAP net income per share $
0.23 $ 0.09 $ 0.34 $ 0.28 Shares used
in diluted per share calculation 48,808 51,175
(i) 49,498 49,293 (i)
(a) This table contains financial measures
that are not calculated in accordance with U.S. generally accepted
accounting principles (GAAP). Such measures are intended to serve
as a supplement to the GAAP results presented elsewhere in this
press release, and should not be considered in isolation or as a
substitute for such GAAP results. See the section entitled
Discussion of Non-GAAP Financial Measures in this press release for
additional information regarding: the manner in which management
uses these non-GAAP financial measures; the economic substance
behind management's decision to use such measures; the material
limitations associated with use of these non-GAAP financial
measures as compared to the use of the most directly comparable
GAAP financial measures; the manner in which management compensates
for these limitations when using these non-GAAP financial measures;
and the substantive reasons why management believes these non-GAAP
financial measures provide useful information to investors.
(b) Amortization of purchased technology
acquired in the Xenos acquisition transaction in February 2010 and
Performancesoft acquisition transaction in January 2006. Purchased
technology is amortized over the estimated life of the underlying
asset.
(c) Amortization of other intangibles
includes identifiable intangible assets including trade names,
employment agreements and customer relationships acquired through
various acquisition transactions. Other identified intangibles are
amortized over the estimated remaining life of the underlying
intangibles.
(d) Actuate accounts for stock-based
compensation expense under the fair value method. Actuate adopted
the authoritative guidance issued by the Financial Accounting
Standards Board ("FASB") related to the measurement and disclosure
of stock-based compensation expense. Stock-based compensation
expense is measured at the grant date based on the fair value of
the award and is recognized as expense over the requisite service
period. For the three months ended September 30, 2010, stock-based
expense included approximately (in thousands): $235, $184, $240,
and $584, related to cost of services revenues, sales and marketing
expense, research and development expense and general and
administrative expense, respectively.
(e) The restructuring expense for the
third quarter of 2010 relates primarily to prior facility closures
in North America. These charges were based on actual and estimated
costs incurred including estimates of sublease income on portions
of our idle facilities that we periodically update based on market
conditions and in accordance with our restructuring plans. The
restructuring expense for the third quarter of 2009 consist of
severance payments, payroll taxes and extended medical benefits
related to a reduction-in-force that was implemented in July 2009.
Included for the 2009 year are charges related to prior facility
closures in North America. These charges were based on actual and
estimated costs incurred including estimates of sublease income on
portions of our idle facilities that we periodically update based
on market conditions and in accordance with our restructuring
plans.
(f) Costs associated with the acquisition of Xenos Group
Inc.
(g) The deferred revenue adjustment
relates to our acquisition of Xenos, Inc, which was concluded in
February of 2010. In accordance with the fair value provisions of
EITF 01-3, Accounting in a Business Combination for Deferred
Revenue of an Acquiree, acquired deferred revenue of approximately
$1.5 million was recorded on the opening balance sheet, which was
approximately $3.0 million lower than the historical carrying
value. This purchase accounting requirement adversely impacts the
Company's reported GAAP revenue primarily for the first twelve
months post-acquisition. In order to provide investors with
financial information that facilitates comparison of both
historical and future results, the Company has provided non-GAAP
financial measures which exclude the impact of the purchase
accounting adjustment.
(h) Income tax expense is adjusted by the
amount of additional expense or benefit that we would accrue if we
used non-GAAP results instead of GAAP results in the calculation of
our tax liability, taking into consideration the company's
long-term tax structure. The Company uses a normalized effective
tax rate of 20%.
(i) Shares used in calculating diluted earnings per share
have been adjusted to reflect what the share amounts would have
been if they were calculated using non-GAAP results.
ACTUATE
CORPORATION CONSOLIDATED STATEMENTS OF CASH FLOWS (in
thousands) (unaudited) Nine
Months Ended September 30, Operating activities
2010 2009 Net
income $ 7,920 $ 8,742 Adjustments to
reconcile net income to net cash from operating activities: Stock
based compensation expense related to stock options and employee
stock purchase plan 4,239 5,367 Tax benefits from stock-based
compensation (536 ) (2,649 ) Amortization of other purchased
intangibles 2,245 675 Amortization of debt issuance cost 215 210
Depreciation 1,422 1,643
Gain on Auction Rate Securities
(1,934 ) (678 )
Loss on fair value of put option
1,921 607
Accretion of discount on short-term debt
securities
256 118 Change in valuation allowance on deferred tax assets (1,548
) (575 ) Changes in operating assets and liabilities, net of
acquired assets and assumed liabilities: Accounts receivable, net
14,343 7,649 Other current assets 2,747 (314 ) Accounts payable
(1,398 ) (1,248 ) Accrued compensation 522 (165 ) Other accrued
liabilities (5,249 ) 131 Deferred tax assets 673 115 Deferred tax
liabilities (24 ) - Income tax receivable 1,009 (1,044 ) Income tax
payable 1,602 1,765 Other deferred liabilities (280 ) (202 )
Restructuring liabilities (1,570 ) (2,640 ) Deferred revenue
(7,559 ) (5,821 ) Net cash provided by
operating activities 19,016
11,686
Investing activities Purchases
of property and equipment (703 ) (1,048 ) Release of restricted
cash - 229 Proceeds from maturity of investments 25,611 13,706
Purchases of short-term investments (24,153 ) (22,243 ) Acquisition
of Xenos Group Inc., net of cash acquired (27,343 ) - Proceeds from
security deposit - 10 Net change in other non-current assets
35 (71 ) Net cash used in
investing activities (26,553 )
(9,417 )
Financing activities Proceeds from the
credit facility, net of issuance cost 9,983 - Tax benefit from
exercise of stock options 536 2,649 Proceeds from issuance of
common stock 4,565 7,906 Stock repurchases (9,999 ) (10,039 ) Cost
of tender offer - (258 )
Net cash provided by financing activities 5,085
258 Net increase (decrease) in
cash and cash equivalents (2,452 ) 2,527 Effects of exchange rates
on cash and cash equivalents 920 730 Cash and cash equivalents at
the beginning of the period 53,173
24,772 Cash and cash equivalents at the end of
the period $ 51,641 $ 28,029
Actuate Therapeutics (NASDAQ:ACTU)
Gráfico Histórico do Ativo
De Nov 2024 até Dez 2024
Actuate Therapeutics (NASDAQ:ACTU)
Gráfico Histórico do Ativo
De Dez 2023 até Dez 2024